Mutations linked to breast cancer treatment resistance
Monday, November 4, 2013 - 14:30
in Health & Medicine
Researchers have identified a type of mutation that develops after breast cancer patients take anti-estrogen therapies. The mutations explain one reason why patients often become resistant to this therapy.